EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Laryngeal Preservation with Boron Neutron Capture Therapy for Metachronous Second Primary Head and Neck Cancer in the Pharyngolaryngeal Region Within a Previously Irradiated Field

Takashi Ono, Kanako Takayama, Ichiro Seto, Yoshiaki Takagawa, Shinya Komori, Ryohei Kato, Akihiko Takeuchi, Yuhei Yamazaki, Tomoaki Motoyanagi, Yuki Narita, Shunsuke Komatsu, Takahiro Kato und 1 weitere

Cancers · 20.11.2026 · 18 (22) · 3717

DOI: 10.3390/cancers18223717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 20.11.2026. Verfasst von Takashi Ono und 12 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The occurrence of metachronous second primary head and neck cancer within a previously irradiated field presents a challenging clinical problem because reirradiation can cause severe toxicities. Boron neutron capture therapy (BNCT) may offer a curative treatment option for such tumors while minimizing the risk of severe toxicity. This study aimed to evaluate the feasibility of laryngeal preservation using BNCT for these tumors.

Methods

Patients with metachronous second primary cancer in the pharyngeal or laryngeal region within a previously irradiated field who received BNCT between June 2020 and January 2022 were retrospectively included. Overall survival, laryngeal preservation, and local control were estimated using the Kaplan–Meier method.

Results

All 11 patients achieved a complete response. The follow-up duration for surviving patients exceeded 4 years. The 4-year overall survival, laryngeal preservation, and local control rates were 81.8%, 80.0%, and 70.0%, respectively. No late toxicities of grade 3 or higher were observed. Among the three patients with local recurrence, two underwent salvage surgery (in one case, the patient underwent surgery after receiving BNCT once more). Local control was achieved in both patients without serious toxicities.

Conclusions

BNCT for patients with metachronous second primary head and neck cancer achieved a high response rate and a high rate of laryngeal function preservation, with toxicity remaining within acceptable limits. Moreover, salvage surgery was feasible after BNCT. These findings suggest that BNCT may serve as a larynx-sparing treatment option for metachronous second primary head and neck cancer arising within a previously irradiated field.

Zitieren

APA

Ono, T., Takayama, K., Seto, I., Takagawa, Y., Komori, S., Kato, R., Takeuchi, A., Yamazaki, Y., Motoyanagi, T., Narita, Y., Komatsu, S., Kato, T., & Takai, Y. (2026). Laryngeal Preservation with Boron Neutron Capture Therapy for Metachronous Second Primary Head and Neck Cancer in the Pharyngolaryngeal Region Within a Previously Irradiated Field. Cancers, 18(22), 3717. https://doi.org/10.3390/cancers18223717

Vancouver

Ono T, Takayama K, Seto I, Takagawa Y, Komori S, Kato R, et al. Laryngeal Preservation with Boron Neutron Capture Therapy for Metachronous Second Primary Head and Neck Cancer in the Pharyngolaryngeal Region Within a Previously Irradiated Field. Cancers. 2026;18(22):3717. doi:10.3390/cancers18223717

BibTeX
@article{Ono2026,
  author = {Ono, Takashi and Takayama, Kanako and Seto, Ichiro and Takagawa, Yoshiaki and Komori, Shinya and Kato, Ryohei and Takeuchi, Akihiko and Yamazaki, Yuhei and Motoyanagi, Tomoaki and Narita, Yuki and Komatsu, Shunsuke and Kato, Takahiro and Takai, Yoshihiro},
  title = {Laryngeal Preservation with Boron Neutron Capture Therapy for Metachronous Second Primary Head and Neck Cancer in the Pharyngolaryngeal Region Within a Previously Irradiated Field},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3717},
  doi = {10.3390/cancers18223717}
}
Kostenlos starten →